1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists
(
- Contribution to journal › Scientific review
-
Mark
A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells.
(
- Contribution to journal › Article
- 2012
-
Mark
Neighborhood deprivation and prostate cancer mortality: a multilevel analysis from Sweden.
(
- Contribution to journal › Article
- 2010
-
Mark
Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.
(
- Contribution to journal › Article
- 2009
-
Mark
Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia
(
- Contribution to journal › Article
- 2006
-
Mark
Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer
(
- Contribution to journal › Article
- 2004
-
Mark
Long-term testosterone stimulation induces hyperplasia in the guinea-pig prostate.
(
- Contribution to journal › Article
- 2000
-
Mark
Studies on phenotypic expression patterns of proteases and protease inhibitors in benign compared to malignant prostate tissues
(
- Contribution to journal › Article
- 1999
-
Mark
Early Diagnosis and Staging.
(
- Contribution to journal › Article